Griffin Deborah A 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 14, 2019
Insider Transaction Report
Form 4
Griffin Deborah A
Chief Accounting Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2019-03-12+953→ 953 total - Sale
Ordinary Shares
2019-03-12$15.67/sh−953$14,938→ 0 total - Exercise/Conversion
Restricted Share Units
2019-03-12−953→ 0 total→ Ordinary Shares (953 underlying)
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.6600 to $15.6911, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Restricted share units were granted on March 12, 2015, with 952 vesting on March 12, 2018 and 953 vesting on March 12, 2019.